Novel conditionally active ADCs (CAB ADCs): A novel class of molecules targeting solid tumors

February 2, 2023

Anti-Tumor Efficacy of BA3021

January 31, 2023

Anti-Tumor Efficacy of BA3011

January 31, 2023

Novel Conditionally Active Biologic anti-Axl ADC Demonstrates Anti-Tumor Efficacy and Improved Safety Profile

January 31, 2023